Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Relevant Research Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomised controlled trials Retatrutide for the treatment of obesity, obstructive sleep apnea, and knee osteoarthritis: rationale and design of the TRIUMPH registrational clinical trials Retatrutidea game changer in obesity pharmacotherapy Unleashing the power of retatrutide: a possible triumph over obesity Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomised phase 2a trial Retatrutide in type 2 diabetes mellitus and obesity: an overview
Cost Comparison by Application Monthly Cost Estimates For detailed cost calculations , factor in concentration, application frequency, and whether you are using topical, injectable, or both
Not for human or veterinary consumption BAM15 RESEARCH FACTS Units per Bottle: 30 Unit Size: 50 mg Total Active Amount: 1,500 mg Net Volume: 30 ml Compound: N5,N6-Bis(2-fluorophenyl)[2,1,3]oxadiazolo[4,5-b]pyrazine-5,6-diamine (BAM15)
Most peptides break down within minutes in the acidic environment of the stomach
US$ 21.45
US$ 27.67
US$ 27.81
US$ 25.79
